Title | COVID-19 Vaccination Status and Concerns Among People Who Use Drugs in Oregon. |
Publication Type | Journal Article |
Year of Publication | 2022 |
Authors | Stack, E, Shin, S, LaForge, K, Pope, J, Leichtling, G, Larsen, JE, Byers, M, Leahy, JM, Hoover, D, Chisholm, L, P Korthuis, T |
Journal | J Addict Med |
Volume | 16 |
Issue | 6 |
Pagination | 695-701 |
Date Published | 2022 Nov-Dec 01 |
ISSN | 1935-3227 |
Keywords | COVID-19, COVID-19 Vaccines, Health Personnel, Humans, Oregon, Vaccination |
Abstract | OBJECTIVES: The objective of this study was to examine COVID-19 vaccination acceptance and explore reasons for COVID-19 vaccine hesitancy among people who use drugs (PWUDs), a population with increased COVID-19 transmission and morbidity. METHODS: We conducted semi-structured in-depth interviews with PWUDs in 7 Oregon counties from May 11 to June 25, 2021. Participants (n = 34) were recruited in partnership with syringe service programs and local community organizations staff, participant-referrals, and flyer advertising. Research staff conducted interviews via telephone to assess participants' acceptance of the COVID-19 vaccine, find knowledge gaps where new educational information about vaccination would be helpful, and identify who would be perceived as a trustworthy source of information. Interviews were transcribed and coded using thematic analysis with a deductive approach. RESULTS: Most participants had not received the COVID-19 vaccine and were not planning on or were unsure about receiving it. Participants were mistrustful of the rapid COVID-19 vaccine development process, the agencies involved in the development, and vaccines in general. Participants shared varied and contrasting responses about who they would trust to provide information about the COVID-19 vaccine, including peer recovery support specialists, doctors, or other health care professionals, and specified federal agencies or media outlets. CONCLUSIONS: As addiction medicine and public health staff continue to respond to the evolving impacts of COVID-19, vaccination planning should be tailored to the unique needs of PWUD to increase COVID-19 vaccine acceptance in this high-risk population. |
DOI | 10.1097/ADM.0000000000001002 |
Alternate Journal | J Addict Med |
PubMed ID | 35797436 |
PubMed Central ID | PMC9653059 |
Grant List | UG1 DA015815 / DA / NIDA NIH HHS / United States UH3 DA044831 / DA / NIDA NIH HHS / United States |